We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$6.93B
AUM Growth
+$1.84B
Cap. Flow
+$1.42B
Cap. Flow %
20.44%
Top 10 Hldgs %
40.16%
Holding
121
New
33
Increased
24
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$628M
2
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$165M
3
QCOR
QUESTCOR PHARMA INC
QCOR
+$159M
4
HSH
HILLSHIRE BRANDS CO
HSH
+$138M
5
AGN
Allergan Inc
AGN
+$95.4M

Top Sells

Rank Stock Value
1
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$251M
2
DG icon
Dollar General
DG
+$180M
3
CHTR icon
Charter Communications
CHTR
+$99.8M
4
DIS icon
Walt Disney
DIS
+$97.1M
5
SIRI icon
SiriusXM
SIRI
+$67.6M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Consumer Discretionary 12.11%
3 Real Estate 9.7%
4 Consumer Staples 9.58%
5 Communication Services 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCIP
76
DELISTED
OCI Partners LP
OCIP
$4.22M 0.06%
198,592
-301,408
-60% -$6.39M
OIS icon
77
Oil States International
OIS
$489M
$3.27M 0.05%
+51,050
New +$3M
KIN
78
DELISTED
Kindred Biosciences, Inc.
KIN
$3.26M 0.05%
+175,000
New +$2.97M
EIGR
79
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.2M 0.05%
444
-160
-26% -$801K
TPH
80
DELISTED
Tri Pointe Homes
TPH
$2.52M 0.04%
+160,000
New +$2.59M
CNL
81
DELISTED
CLECO CRP (HOLDING CO)
CNL
$2.29M 0.03%
+38,894
New +$2.03M
GRFS
82
Grifois
GRFS
$5.36B
$2.26M 0.03%
102,764
-2,028,090
-95% -$42.4M
ALDR
83
DELISTED
Alder Biopharmaceuticals
ALDR
$2.01M 0.03%
+100,000
New +$1.41M
ARQL
84
DELISTED
Arqule Inc
ARQL
$1.95M 0.03%
1,258,732
– –
ACAD icon
85
Acadia Pharmaceuticals
ACAD
$4.43B
$1.58M 0.02%
70,000
– –
FATE icon
86
Fate Therapeutics
FATE
$286M
$1.57M 0.02%
248,102
-26,898
-10% -$189K
EGRX
87
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.43M 0.02%
100,000
– –
STML
88
DELISTED
Stemline Therapeutics, Inc.
STML
$1.39M 0.02%
95,000
– –
CORI
89
DELISTED
Corium International, Inc.
CORI
$971K 0.01%
+125,000
New +$942K
QURE icon
90
uniQure
QURE
$3.03B
$680K 0.01%
50,000
– –
IBP icon
91
Installed Building Products
IBP
$6.01B
$593K 0.01%
48,398
-130,426
-73% -$1.74M
NGNE icon
92
Neurogene
NGNE
$656M
$451K 0.01%
2,405
-95
-4% -$18.3K
ANIP icon
93
ANI Pharmaceuticals
ANIP
$1.8B
– –
-30,000
Closed -$941K
CPF icon
94
Central Pacific Financial
CPF
$1.02B
– –
-306,042
Closed -$6.18M
CYH icon
95
Community Health Systems
CYH
$393M
– –
-302,500
Closed -$9.79M
DG icon
96
Dollar General
DG
$28B
– –
-3,245,000
Closed -$180M
DIS icon
97
Walt Disney
DIS
$167B
– –
-1,212,500
Closed -$97.1M
FBIO icon
98
Fortress Biotech
FBIO
$104M
– –
-3,933
Closed -$117K
IRM icon
99
Iron Mountain
IRM
$36.4B
– –
-968,390
Closed -$24.7M
MCK icon
100
McKesson
MCK
$100B
– –
-86,500
Closed -$15.3M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, Farallon Capital Management held 121 positions worth $6.93B, up 36% from $5.09B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Farallon Capital Management deployed $1.42B of net new capital in Q2 2014, opening 33 new positions and adding to 24 existing holdings. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 2,200,000 shares worth $198M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 7.4% a quarter earlier, followed by Consumer Discretionary and Real Estate.

On the sell side, the largest reduction was Charter Communications, an estimated $99.8M trimmed.

  • Farallon Capital Management's largest Q2 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 2,200,000 shares worth $198M.
  • Farallon Capital Management added most to FOREST LABORATORIES INC in Q2 2014, an estimated $628M increase.
  • Farallon Capital Management's biggest Q2 2014 reduction was Charter Communications, cutting an estimated $99.8M.
  • Farallon Capital Management fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2014, selling an estimated $251M.
  • Farallon Capital Management's ten largest holdings make up 40% of its $6.93B portfolio in Q2 2014.
  • Farallon Capital Management opened 33 new positions and closed 24 in Q2 2014.
  • Farallon Capital Management's portfolio value rose 36% quarter-over-quarter to $6.93B.

Based on Farallon Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.